These five super-aggressive biotech stocks are all rated Buy at well-known Wall Street firms and are suitable for very aggressive investors that have a high-risk tolerance.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including BlackBerry, BHP, Lam Research, Shopify, Square and Zoom Video Communications.
Tuesday was a down day for the broad U.S. markets. While the S&P 500 and Nasdaq were marginally positive on Monday, they gave back all their gains and then some in Tuesday’s session. Although...
Affimed shares took a big step back early on Tuesday after the company announced that it has placed its AFM11 on clinical hold, and has notified the global health authorities of its decision.
Affimed shares more than doubled early on Tuesday after it was announced that the firm entered into a strategic collaboration agreement with Genentech.
The top analyst upgrades, downgrades and initiations seen on Tuesday include Affimed, Coty, Cree, Lululemon Athletica, Myriad Genetics, Tesla and Xilinx.
Tuesday was a relatively positive day for the broad U.S. markets, with all the major averages edging up. Crude oil was again positive on the day but only marginally. The S&P 500 sectors were...
Affimed N.V. (NASDAQ: AFMD) shares dropped sharply early on Friday after the firm released new results from its early stage trial with Keytruda. The firm presented new interim data from the Phase 1b...
The include Axalta, Baidu, Cypress Semi, Merck, Microsoft, Switch top analyst upgrades, downgrades and other research calls from Tuesday.
The top analyst upgrades, downgrades and other research calls from Tuesday include Apple, Chesapeake Energy, DowDuPont, Equifax, Gap, Nike, Tesla and Under Armour.
The top analyst upgrades, downgrades and other research calls from Thursday include Bank of America, Cerner, Delta Air, Goldman Sachs, JPMorgan, Stratasys and Synacor.
February 17, 2016: Here are four stocks trading with heavy volume among 42 equities making new 52-week lows today. Devon Energy Corp. (NYSE: DVN) dropped about 13.5% on Wednesday to post a new...
Affimed shares rose on Monday following the announcement of a collaboration in immuno-oncology with biotech giant Merck.
These are the top analyst upgrades and stocks to buy for August 14, 2013, including Brocade, Hovnanian, SINA and more.
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Monday.Apple Inc. (NASDAQ: AAPL) cut to Neutral and target cut to $575 from...